De
Da
En
Fr
Sv
Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Märkte
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
De
Da
En
Fr
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
22 Aug 2024
Equity Research GIAB, Q2 2024: Getting to break even with a better plan
Equity Research
GIAB
15 Aug 2024
Equity Research GIAB Q2 2024: Results slightly better than expected
Equity Research
GIAB
21 Mai 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research
GIAB
16 Mai 2024
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
Equity Research
GIAB
26 Feb 2024
Initiation of coverage GIAB: More profitable by focusing on electronics
Equity Research
GIAB